We next wanted to determine whether any of the IL-1β targeting therapies were affecting bacterial numbers at the infection site, as inhibition of wound formation could be due to changes in the recruitment and activation of immune cells, a decrease in cytokine-driven host cytotoxicity in the infected tissue, and/or direct bacterial cytotoxicity. This evidence concerns the gene IL1B and infection.